European Cancer Organisation

European Cancer Organisation Working together to build consensus and achieve improvement in cancer care.

The European Cancer Organisation

Our Mission

To reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism. As the not-for-profit federation of member organisations working in cancer at a European level, we convene oncology professionals and patients to agree policy, advocate for positive change and be the unite

d voice of the European cancer community. Our Vision

To be a vibrant, pro-active, focused, relevant and influential federation, working together for a cancer free future, ensuring that every patient has high quality care and treatment, with access to the full range of professionals needed. To create and develop ever-strengthening relationships between European institutions and the European cancer care community, and with our Member Societies and networks, facilitate collaboration and consensus on focused topics towards tangible and impactful policy improvement. Our Values

Our essential and enduring values are:

-Patient Centricity – Putting cancer patients at the centre of our concerns and activities and strive to do the best for them

- Commitment to Science – Reflecting the very latest scientific knowledge and be completely independent of any vested interests

- Cohesiveness – We believe in the power of combining the efforts of our members and other stakeholders who have a common mission

- Inclusiveness – We seek to include all non-profit organisations that share our mission, vision and values

- Equality and Fairness – All our members have a voice in the organisation and we strive to transcend the interests of any one member

- Openness and Transparency – We are committed to be transparent in and accountable for all that we do

The INTERACT-EUROPE 100 Enhanced Final Programme is now accepting applications!Cancer centres across Europe are invited ...
09/06/2026

The INTERACT-EUROPE 100 Enhanced Final Programme is now accepting applications!

Cancer centres across Europe are invited to join the final implementation cycle of , supporting interdisciplinary collaboration and excellence in patient-centred cancer care.

Following the project’s successful previous iteration – with 107 cancer centres across 26 countries and more than 1,100 healthcare professionals enrolled – the enhanced edition offers a more focused learning experience, tailored online and onsite opportunities, micro-credentials where applicable, and access to a growing European network advancing interdisciplinary oncology education.

Participation is free of charge for eligible organisations.

Apply by 23 June: https://www.europeancancer.org/eu-projects/impact/interact-europe-100

Three EU-funded projects and one shared goal: strengthening age-appropriate cancer care for adolescents and young adults...
09/06/2026

Three EU-funded projects and one shared goal: strengthening age-appropriate cancer care for adolescents and young adults (AYAs) across Europe.

The online Joint AYA Stakeholder Forum will bring together:

🔹 PanCare4AYA, advancing survivorship care
🔹 PredictAYA, improving understanding of long-term and reproductive health outcomes
🔹 STRONG-AYA, strengthening care through core outcomes and data-driven approaches

Join the discussion on Tuesday 30 June, 15:00-17:00 CEST.

🔗 Register here: https://www.europeancancer.org/events/436:transforming-aya-cancer-care-from-research-to-practice.html -form

Adolescents and young adults with cancer (AYAs) face specific clinical and psychosocial needs during and after treatment...
04/06/2026

Adolescents and young adults with cancer (AYAs) face specific clinical and psychosocial needs during and after treatment.

These can include late effects of therapy – including fertility and reproductive health issues – and impacts on mental health and quality of life.

On 30 June, the EU-funded PanCare4AYA, PredictAYA and STRONG-AYA projects will host an online Joint AYA Stakeholder Forum to discuss how research can be translated into better care, guidelines and policy across Europe.

🔗 Register now: https://www.europeancancer.org/events/436:transforming-aya-cancer-care-from-research-to-practice.html -form

The EU’s next long-term budget must reflect the priorities of its citizens. And that means better healthcare for all.Tha...
04/06/2026

The EU’s next long-term budget must reflect the priorities of its citizens. And that means better healthcare for all.

That’s why more than 490 healthcare experts, scientists, academics, and patient advocates have sent a joint letter to the heads of European institutions and national governments calling for health to be protected in the next EU budget.

Hear more about it from Isabel Rubio, President of the European Cancer Organisation.

Read the letter 📩 https://www.europeancancer.org/policy/key-opinion-leaders-call-for-a-strong-eu-health-budget

€442 billion lost every year. 🚨 That’s the price Europe pays in lost productivity due to premature deaths caused by non-...
03/06/2026

€442 billion lost every year. 🚨
That’s the price Europe pays in lost productivity due to premature deaths caused by non-communicable diseases.

The EU’s next long-term budget is being shaped around competitiveness and resilience, but there can be no competitive Europe without healthy people.

That’s why more than 490 healthcare experts, scientists, academics, and patient advocates have sent a joint letter to EU leaders and national governments calling for a dedicated and ringfenced health budget.

The European Parliament has already backed this call. Now it is time to ensure member states do the same.

Read the letter here 📄 https://www.europeancancer.org/policy/key-opinion-leaders-call-for-a-strong-eu-health-budget

Early diagnosis saves lives. 📈For common cancers, early-stage diagnosis can raise survival by up to 13 times.📉By contras...
02/06/2026

Early diagnosis saves lives.

📈For common cancers, early-stage diagnosis can raise survival by up to 13 times.
📉By contrast, late-stage detection can reduce survival rates to below 10% after five years.

The issue: we know how to detect cancer earlier through screening, yet implementation varies dramatically between and within countries.

Following the success of the 2024 edition, the new Screening Policy Index introduces
➡️ a single measurement benchmarking a country’s progress in cancer screening, and
➡️ actionable policy insights to assist decision-makers

Download the Index and capture the current state of cancer screening policies across European countries 🌐 europeancancer.org/screeningindex

⚠️ To***co consumption accounts for 700,000 deaths in the EU every year.Yet, nearly 20 % of people aged 15 years and ove...
31/05/2026

⚠️ To***co consumption accounts for 700,000 deaths in the EU every year.

Yet, nearly 20 % of people aged 15 years and over in the EU are daily smokers. Even worse, novel ni****ne and to***co products are reaching more and more young people. 🚭

Europe is aiming to create a to***co-free generation by 2040. The ambition is set. Now the policy needs to deliver:

➡️ By revising the To***co Taxation Directive – and including novel to***co and ni****ne products – the European Union can help make these products less affordable and less attractive.

➡️ By adopting the To***co Excise Duty Own Resource proposed under the EU's next long-term budget, the EU could generate an estimated €11.2 billion annually for health and cancer prevention

➡️ By strengthening the existing rules in the upcoming To***co Products Directive and To***co Advertising Directive, which the European Commission is currently consulting on, the EU can promote healthier lifestyles and prevent people from picking up the habit in the first place.

This World No To***co Day, the Parliamentary Intergroup on Cancer and Rare Diseases sends a clear message: Europe must stay ambitious on to***co prevention, regulation and taxation.

Read the publication issued by the Intergroup Secretariat here 🌐 www.intergrouponcancerandrarediseases.eu/news/world-no-to***co-day-2026

Tilly Metz Vlad Voiculescu Alessandra Moretti Tomislav Sokol

⚠️ Smoking causes 27% of all cancer cases in Europe. Each year, this leads to 700K deaths which could have been prevente...
31/05/2026

⚠️ Smoking causes 27% of all cancer cases in Europe. Each year, this leads to 700K deaths which could have been prevented.

As we mark ***coDay, we reflect on the need to advance these goals and secure their legacy in the next phase of European cancer cooperation.

Last July, the European Commission put forward a proposal for the Revised To***co Taxation Directive, pushing for increased taxation on to***co products, including the extension of excise duties to novel to***co and ni****ne products.

This March, the European Parliament voted to support the proposal. Now, it is time for the Council of the EU to prepare its position. Negotiations are set to be concluded as early as the end of this year.

The European Cancer Organisation and its member societies across the continent are urging governments to seize this once-in-a-generation opportunity to save hundreds of thousands of lives. 🚭

Learn more about the Directive and our joint letter to the Cypriot Presidency of the Council 🔗https://www.smokefreepartnership.eu/news/joint-letter-civil-society-concerns-regarding-current-negotiations-on-the-eu-to***co-tax-directive

Digital health has the potential to transform cancer care across Europe, but only if it remains accessible, trustworthy ...
30/05/2026

Digital health has the potential to transform cancer care across Europe, but only if it remains accessible, trustworthy and patient-centred. 💻

This , we highlight the importance of stronger European collaboration on cancer information, health data and digital tools.

Through projects such as EU-CIP and CANDLE, we are working to:
🌍 Improve access to reliable cancer information
🔗 Strengthen collaboration between cancer data initiatives
👥 Support more patient-centred digital health systems across Europe

Better digital infrastructure means better research, better policymaking and, ultimately, better outcomes for patients.

Discover EU-CIP: https://cancerinfoportal.eu/

Read more about CANDLE: https://candle-project.eu/

29/05/2026

What once seemed like a bold ambition is now becoming reality.

When was first conceived, the goal was to certify 400 professionals across Europe.

Now, only halfway through its implementation, that target has already been reached.

With many participants still due to complete the programme in the coming months, INTERACT-EUROPE 100 is on track to surpass expectations.

Discover more: https://www.europeancancer.org/eu-projects/impact/resource/selected-cancer-centres-for-interact-europe-100.html

Adres

Rue De La Science 41
Brussels
1040

Openingstijden

Maandag 08:30 - 17:00
Dinsdag 08:30 - 17:00
Woensdag 08:30 - 17:00
Donderdag 08:30 - 17:00
Vrijdag 08:30 - 17:00

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer European Cancer Organisation nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Delen